Full name
SUPERNOVA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 999,6 | |||
Gross profit (loss) | -0 | -0,7 | -0,4 | 46,1 |
EBITDA | -0 | -0,6 | -0,3 | 50,6 |
Short time liabilities | 0,5 | 2,7 | 2,9 | 5,7 |
Other operating costs | 7,6 | |||
Equity capital | -0,2 | -0,8 | -0,3 | 63 |
Operating profit (EBIT) | -0 | -0,6 | -0,3 | 51 |
Assets | 0,4 | 1,9 | 2,7 | 41,5 |
Net profit (loss) | -0 | -0,7 | -0,4 | 46,1 |
Cash | 0,1 | 0,8 | 1,2 | 53,7 |
Liabilities and provisions for liabilities | 0,6 | 2,7 | 3 | 9,6 |
Net income from sale | 2,3 | 3,3 | 7,2 | 118 |
Working assets | 0,3 | 1,8 | 2,6 | 44,1 |
Other income costs | 783,4 | |||
Depreciation | 0 | 0,1 | 0 | -53,9 |
% | % | % | p.p. | |
Profitability of capital | 21,4 | 79 | 114,9 | 35,9 |
Equity capital to total assets | -45 | -43,9 | -11,5 | 32,4 |
Gross profit margin | -1,6 | -20 | -4,9 | 15,1 |
EBITDA Margin | -0,1 | -16,8 | -3,8 | 13 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 86 | 300 | 146 | -154 |
Current financial liquidity indicator | 4 | |||
Net dept to EBITDA | -13 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane